Abstract
It is the aim of this chapter to review the major advances that occurred during 1976 with regard to our knowledge about the metabolism of the major plasma lipids and lipoproteins and about clinical abnormalities in lipid transport, with particular emphasis on the hyperlipidemias. The chapter will build on, and in part briefly summarize, the information and ideas reviewed last year (Goodman, 1976), and will also review briefly some other major developments that occurred before 1976 in order to provide important background information.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahrens, E. H., Jr., 1969, Mass field trials of the diet-heart question: Their significance, timeliness, feasibility, and applicability, Report of the Diet-Heart Panel of the National Heart Institute, Amer. Heart Assoc. Monogr. No. 28, American Heart Association, New York (now Dallas, Texas).
Albers, J. J., Cabana, V. G., Warnick, G. R., and Hazzard, W. R., 1975, Lp(a) lipoprotein: Relationship to sinking pre-β lipoprotein, hyperlipoproteinemia, and apolipoprotein B, Metabolism 24:1047–1054.
Albers, J. J., Wahl, P. W., Cabana, V. G., Hazzard, W. R., and Hoover, J. J., 1976, Quantitation of apolipoprotein A-I of human plasma high density lipoprotein, Metabolism 25:633–644.
Andersen, J. M., and Dietschy, J. M., 1976, Cholesterogenesis: Derepression in extrahepatic tissues with 4-aminopyrazolo[3,4-d]pyrimidine, Science 193:903–905.
Anderson, J. T., Grande, F., and Keys, A., 1976, Independence of the effects of cholesterol and degree of saturation of the fat in the diet on serum cholesterol in man, Amer. J. Clin. Nutr. 29:1184–1189.
Anderson, R. G. W., Goldstein, J. L., and Brown, M. S., 1976, Localization of low density lipoprotein receptors on plasma membrane of normal human fibroblasts and their absence in cells from a familial hypercholesterolemia homozygote, Proc. Natl. Acad. Sci. U.S.A. 73:2434–2438.
Balasubramaniam, S., Goldstein, J. L., Faust, J. R., and Brown, M. S., 1976, Evidence for regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol synthesis in nonhepatic tissues of rat, Proc. Natl. Acad. Sci. U.S.A. 73:2564–2568.
Basii, S. K., Goldstein, J. L., Anderson, R. G. W., and Brown, M. S., 1976, Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts, Proc. Natl. Acad. Sci U.S.A. 73:3178–3182.
Berg, K., Børresen, A.-L., and Dahlén, G., 1976, Serum-high-density-lipoprotein and atherosclerotic heart-disease, Lancet 1:499–501.
Bhattacharyya, A. K., and Connor, W. E., 1974, β-Sitosterolemia and xanthomatosis: A newly described lipid storage disease in two sisters, J. Clin. Invest. 53:1033–1043.
Bloch, A., Dinsmore, R. E., and Lees, R. S., 1976, Coronary arteriographic findings in type-II and type-IV hyperlipoproteinaemia, Lancet 1:928–930.
Brown, M. S., and Goldstein, J. L., 1976a, Receptor-mediated control of cholesterol metabolism: Study of human mutants has disclosed how cells regulate a substance that is both vital and lethal, Science 191:150–154.
Brown, M. S., and Goldstein, J. L., 1976b, Familial hypercholesterolemia: A genetic defect in the low-density lipoprotein receptor, N. Engl. J. Med. 294:1386–1390.
Brown, M. S., and Goldstein, J. L., 1976c, Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein, Cell 9:663–674.
Brown, M. S., Ho, Y. K., and Goldstein, J. L., 1976a, The low-density lipoprotein pathway in human fibroblasts: Relation between cell surface receptor binding and endocytosis of low-density lipoprotein, Ann. N.Y. Acad. Sci. 275:244–257.
Brown, M. S., Sobhani, M. K., Brunschede, G. Y., and Goldstein, J. L., 1976b, Restoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts,J. Biol. Chem. 251:3277–3286.
Brunzell, J. D., Schrott, H. C., Motulsky, A. G., and Bierman, E. L., 1976, Myocardial infarction in the familial forms of hypertriglyceridemia, Metabolism 25:313–320.
Buchwald, H., Moore, R. B., and Varco, R. L., 1974a, Ten years clinical experience with partial ileal bypass in management of the hyperlipidemias, Ann. Surg. 180:384–392.
Buchwald, H., Moore, R. B., and Varco, R. L., 1974b, Surgical treatment of hyperlipidemia, Circulation 49(Suppl. I): 1–37.
Carew, T. E., Hayes, S. B., Koschinsky, T., and Steinberg, D., 1976, A mechanism by which high-density lipoproteins may slow the atherogenic process, Lancet 1:1315–1317.
Carlson, L. A., and Böttiger, L. E., 1972, Ischemic heart disease in relation to fasting values of plasma triglycerides and cholesterol, Lancet 1:865–868.
Cattran, D. C., Fenton, S. S. A., Wilson, D. R., and Steiner, G., 1976, Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis, Ann. Intern. Med. 85:29–33.
Connor, W. E., and Connor, S. L., 1972, The key role of nutritional factors in the prevention of coronary heart disease, Prev. Med. 1:49–83.
Cywes, S., Davies, M. R. Q., Louw, J. H., Berger, G. M. B., Bonnici, F., and Joffe, H. S., 1976, Portacaval shunt in two patients with homozygous type II hyperlipoproteinaemia, S. Afr. Med. J. 50:239–243.
Dahlén, G., Berg, K., and Frick, M. H., 1976, Lp(a) lipoprotein, pre-β 1-lipoprotein, serum lipids and atherosclerotic disease, Clin. Genet. 9:558–566.
Daubresse, J. C., Lerson, G., Plomteux, G., Rorive, G., Luyckx, A. S., and Lefebvre, P. J., 1976, Lipids and lipoproteins in chronic uraemia: A study of the influence of regular haemodialysis, Eur. J. Clin. Invest. 6:159–166.
Dawber, T. R., 1973, Risk factors in young adults: The lessons from epidemiologic studies of cardiovascular disease—Framingham, Tecumseh, and Evans County, J. Amer. Coll. Health Assoc. 22:84–95.
Dayton, S., Pearce, M. L., Hashimoto, S., Dixon, W. V., and Tomiyasu, V., 1969, A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis, Circulation 40(Suppl. II): 1–63.
Dyer, A. R., 1975, An analysis of the relationship of systolic blood pressure, serum cholesterol, and smoking to 14-year mortality in the Chicago Peoples Gas Company study. I. Total mortality in exponential-Weibull model, J. Chron. Dis. 28:565–570.
Eisenberg, S., and Levy, R. I., 1975, Lipoprotein metabolism, in: Advances in Lipid Research, Vol. 13 (R. Paoletti and D. Kritchevsky, eds.) pp. 1–89, Academic Press, New York.
Fallat, R. W., and Glueck, C. J., 1976, Familial and acquired type V hyperlipoproteinemia, Atherosclerosis 23:41–62.
Fallat, R. W., Glueck, C. J., Lutmer, R., and Mattson, F. H., 1976, Short term study of sucrose polyester, a nonabsorbable fat-like material, as a dietary agent for lowering plasma cholesterol, Amer. J. Clin. Nutr. 29:1204–1215.
Farriaux, J.-P., Ribet, M., Bertrand, M., Higgins, M., Mazzuca, M., and Luyckx, A., 1976, Traitement de l’hypercholésterolémie familiale de type II par shunt porto-cave, Arch. Fr. Pediatr. 33:745–759.
Frerichs, R. R., Srinivasan, S. R., Webber, L. S., and Berenson, G. S., 1976, Serum cholesterol and triglyceride levels in 3,446 children from a biracial community: The Bogalusa heart study, Circulation 54:302–309.
Ganesan, D., Bass, H. B., McConathy, W. J., and Alaupovic, P., 1976, Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-β-disease) a cause or an effect of increased apolipoprotein E levels?, Metabolism 25:1189–1195.
Ginsberg, H., Olefsky, J. M., Kimmerling, G., Crapo, P., and Reaven, G. M., 1976, Induction of hypertriglyceridemia by a low-fat diet, J. Clin. Endocrinol. Metab. 42:729–735.
Glomset, J. A., 1968, The plasma lecithin: cholesterol acyltransferase reaction, J.Lipid Res. 9:155–167.
Glueck, C. J., Fallat, R. W., Millett, F., Gartside, P., Elston, R. C., and Go, R. C. P., 1975, Familial hyper-alpha-lipoproteinemia: Studies in eighteen kindreds, Metabolism 24:1243–1265.
Glueck, C. J., Fallat, R. W., Mellies, M. J., and Steiner, P. M., 1976a, Pediatric familial type III hyperlipoproteinemia, Metabolism 25:1269–1274.
Glueck, C. J., Gartside, P., Fallat, R. W., Sielski, J., and Steiner, P. M., 1976b, Longevity syndromes: Familial hypobeta and familial hyperalpha lipoproteinemia, J. Lab. Clin. Med. 88:941–957.
Glueck, C. J., Mellies, M. J., Srivastava, L., Knowles, H. C. Jr., Fallat, R. W., Tsang, R. G., Wacholder, S., and Buncher, G. R., 1977, Insulin, obesity, and triglyceride interrelationships in sixteen children with familial hypertriglyceridemia, Pediatr. Res. 11:13–18.
Goldstein, J. L., and Brown, M. S., 1976, The LDL pathway in human fibroblasts: A receptor-mediated mechanism for the regulation of cholesterol metabolism, in: Current Topics in Cellular Regulation, Vol. II (B. L. Horecker and E. R. Stadtman, eds.) pp. 147–178, Academic Press, New York.
Goldstein, J. L., Basu, S. K., Brunschede, G. Y., and Brown, M. S., 1976a, Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans, Cell 7:85–95.
Goldstein, J. L., Sobhani, M. K., Faust, J. R., and Brown, M. S., 1976b, Heterozygous familial hypercholesterolemia: Failure of normal allele to compensate for mutant allele at a regulated genetic locus, Cell 9:195–203.
Goodman, DeW. S., 1974, Vitamin A transport and retinol-binding protein metabolism, Vitam. Harm. 32:167–180.
Goodman, DeW. S., 1976, Disorders of lipid and lipoprotein metabolism, in: The Year in Metabolism 1975–1976 (N. Freinkel, ed.), pp. 153–180, Plenum Press, New York.
Goodman, DeW. S., Noble, R. P., and Dell, R. B., 1973, Three-pool model of the long-term turnover of plasma cholesterol in man, J. Lipid Res. 14:178–188.
Grundy, S. M., 1975, Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia, J. Clin. Invest. 55:269–282.
Grundy, S. M., and Ahrens, E. H., Jr., 1969, Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotopic kinetic and sterol balance methods, J.Lipid Res. 10:91–107.
Harvengt, C., and Desager, J.-P., 1976, Colestipol in familial type II hyperlipoproteinemia: A three-year trial, Clin. Pharmacol. Ther. 20:310–314.
Hazzard, W. R., and Bierman, E. L., 1976, Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-β disease (type III hyperlipoproteinemia), Metabolism 25:777–801.
Heiberg, A., 1976, Inheritance of xanthomatosis and hyper-β-lipoproteinaemia: A study of 7 large kindreds, Clin. Genet. 9:92–111.
Heiberg, A., and Berg, K., 1976, The inheritance of hyperlipoproteinaemia with xanthomatosis: A study of 132 kindreds, Clin. Genet. 9:203–233.
Heinle, R. A., Levy, R. I., Fredrickson, D. S., and Gorlin, R., 1969, lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease, Amer. J. Cardiol. 24:178–186.
Ho, Y. K., Brown, M. S., Bilheimer, D. W., and Goldstein, J. L., 1976a, Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes, J. Clin. Invest. 58:1465–1474.
Ho, Y. K., Brown, M. S., Kayden, H. J., and Goldstein, J. L., 1976b, Binding, internalization, and hydrolysis of low density lipoprotein in long-term lymphoid cell lines from a normal subject and a patient with homozygous familial hypercholesterolemia, J. Exp. Med. 144:444–455.
Huttunen, J. K., Ehnholm, C., Kekki, M., and Nikkilä, E. A., 1976, Postheparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: Correlations to sex, age and various parameters of triglyceride metabolism, Clin. Sci. Mol. Med. 50:249–260.
Ibels, L. S., Simons, L. A., King, J. O., Williams, P. F., Neale, F. C., and Stewart, J. H., 1975, Studies on the nature and causes of hyperlipidaemia in uraemia, maintenance dialysis and renal transplantation, Q.J. Med. N.S. 44:601–614.
Ibels, L. S., Reardon, M. F., and Nestel, P. J., 1976a, Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients, J. Lab. Clin. Med. 87:648–658.
Ibels, L. S., Alfrey, A. C., Subryan, V., and Weil, R., III, 1976b, Hyperlipide mia following renal transplantation, Trans. Amer. Soc. Artif. Intern. Organs 22:46–53.
Jackson, R. L., Morrisett, J. D., and Gotto, A. M., Jr., 1976, Lipoprotein structure and metabolism, Physiol. Rev. 56:259–316.
Kannel, W. B., Castelli, W. P., Gordon, T., and McNamara, P. M., 1971, Serum cholesterol, lipoproteins, and the risk of coronary heart disease, Ann. Intern. Med. 74:1–12.
Keys, A., 1975, Coronary heart disease: The global picture, Atherosclerosis 22:149–192.
Kudchodkar, B. J., and Sodhi, H. S., 1976, Turnover of plasma cholesteryl esters and its relationship to other parameters of lipid metabolism in man, Eur. J. Clin. Invest. 6:285–298.
Langer, T., Strober, W., and Levy, R. I., 1972, The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia,J. Clin. Invest. 51:1528–1536.
Lauer, R. M., Connor, W. E., Leaverton, P. E., Reiter, M. A., and Clarke, W. R., 1975, Coronary heart disease risk factors in school children: The Muscatine study,J. Pediatr. 86:697–706.
Leren, P., 1970, The Oslo diet-heart study: Eleven year report, Circulation 42:935–942.
Lupien, P.-J., Moorjani, S., and Awad, J., 1976, A new approach to the management of familial hypercholesterolaemia: Removal of plasma-cholesterol based on the principle of affinity chromatography, Lancet 1:1261–1265.
Mahley, R. W., Weisgraber, K. H., Innerarity, T., and Brewer, H. B., 1975, Swine lipoproteins and atherosclerosis: Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding, Biochemistry 14:2817–2823.
Mahley, R. W., Weisgraber, K. H., and Innerarity, T., 1976, Atherogenic hyperlipoproteinemia induced by cholesterol feeding in the Patas monkey, Biochemistry 15:2979–2985.
Manzato, E., Fellin, R., Baggio, G., Walch, S., Neubeck, W., and Seidel, D., 1976, Formation of lipoprotein-X: Its relationship to bile compounds,J. Clin. Invest. 57:1248–1260.
McConathy, W. J., and Alaupovic, P., 1976, Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma, Biochemistry 15:515–520.
Miettinen, M., Turpeinen, O., Karvonen, M. J., Elosuo, R., and Paavilainen, E., 1972, Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes: A twelve year clinical trial in men and women, Lancet 2:835–838.
Miller, G. J., and Miller, N. E., 1975, Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease, Lancet 1:16–19.
Miller, N. E., Nestel, P. J., and Clifton-Bligh, P., 1976, Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in man, Atherosclerosis 23:535–547.
Motulsky, A. G., 1976, Current concepts in genetics: The genetic hyperlipidemias, N. Engl. J. Med. 294:823–827.
Murray, R. G., Tweddel, A., Third, J. L. H. C., Hutton, I., Hillis, W. S., Lorimer, A. R., and Lawrie, T. D. V., 1975, Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia, Br. Heart J. 37:1205–1209.
Myant, N. B., Reichl, D., Thompson, G. R., Higgins, M.J. P., and Galton, D. J., 1976, The metabolism in vivo and in vitro of plasma low-density lipoprotein from a subject with inherited hypercholesterolaemia, Clin. Sci. Mol. Med. 51:463–465.
Norbeck, H.-E., Orö, L., and Carlson, L. A., 1976, Serum lipid and lipoprotein concentrations in chronic uremia, Acta Med. Scand. 200:487–492.
Olefsky, J. M., Crapo, P., and Reaven, G. M., 1976, Postprandial plasma triglyceride and cholesterol responses to a low-fat meal, Amer. J. Clin. Nutr. 29:535–539.
Oliver, M. F., Nimmo, I. A., Cooke, M., Carlson, L. A., and Olsson, A. G., 1975, Ischaemic heart disease and associated risk factors in 40 year old men in Edinburgh and Stockholm, Eur. J. Clin. Invest. 5:507–514.
Pennisi, A. J., Heuser, E. T., Mickey, M. R., Lipsey, A., Malekzadeh, M. H., and Fine, R. N., 1976, Hyperlipidemia in pediatric hemodialysis and renal transplant patients, Amer. J. Dis. Child. 130:957–961.
Rhoads, G. G., Gulbrandsen, C. L., and Kagan, A., 1976, Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men, N. Engl. J. Med. 294:293–298.
Ritland, S., 1975, Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease, Scand. J. Gastroenterol. 10:5–15.
Ross, R., and Glomset, J. A., 1976, The pathogenesis of atherosclerosis, N. Engl. J. Med. 295:369–377, 420–425.
Ross, R., and Harker, L., 1976, Hyperlipidemia and atherosclerosis: Chronic hyperlipidemia initiates and maintains lesions by endothelial cell desquamation and lipid accumulation, Science 193:1094–1100.
Ryan, J. R., Jain, A. K., and McMahon, F. G., 1975, Long-term treatment of hypercholesterolemia with colestipol hydrochloride, Clin. Pharmacol. Ther. 17:83–87.
Salel, A. F., Riggs, K., Mason, D. T., Amsterdam, E. A., and Zelis, R., 1974, The importance of type IV hyperlipoproteinemia as a predisposing factor in coronary artery disease, Amer. J. Med. 57:897–903.
Salen, G., and Grundy, S. M., 1973, The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis, J. Clin. Invest. 52:2822–2835.
Salen, G., Meriwether, T. W., and Nicolau, G., 1975, Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients wtih cerebrotendinous xanthomatosis, Biochem. Med. 14:57–74.
Salen, G., Shefer, S., Zaki, F. G., and Mosbach, E. H., 1977, Inborn errors of bile acid synthesis, Clin. Gastroenterol. 6:91–101.
Shulman, R. S., Bhattacharyya, A. K., Connor, W. E., and Fredrickson, D. S., 1976, β-Sitosterolemia and xanthomatosis, N. Engl. J. Med. 294:482–483.
Sigler, G. F., Soutar, A. K., Smith, L. C., Gotto, A. M., Jr., and Sparrow, J. T., 1976, The solid phase synthesis of a protein activator for lecithin-cholesterol acyltransferase corresponding to human plasma apoC-I, Proc. Natl. Acad. Sci. U.S.A. 73:1422–1426.
Sigurdsson, G., Nicoli, A., and Lewis, B., 1976, Metabolism of very low density lipoproteins in hyperlipidaemia: Studies of apolipoprotein B kinetics in man, Eur. J. Clin. Invest. 6:167–177.
Sing, C. F., Chamberlain, M. A., Block, W. D., and Feiler, S., 1975, Analysis of genetic and environmental sources of variation in serum cholesterol in Tecumseh, Michigan. I. Analysis of the frequency distribution for evidence of a genetic polymorphism, Amer. J. Hum. Genet. 27:333–347.
Slack, J., 1975, The genetic contribution to coronary heart disease through lipoprotein concentrations, Postgrad. Med. J. 51(SuppI. 8):27–32.
Smith, F. R., Dell, R. B., Noble, R. P., and Goodman, DeW. S., 1976, Parameters of the three-pool model of the turnover of plasma cholesterol in normal and hyperlipidemic humans, J. Clin. Invest. 57:137–148.
Sodhi, H. S., and Kudchodkar, B. J., 1973, Synthesis of cholesterol in hypercholesterolemia and its relationship to plasma triglycerides, Metab. (Clin. Exp.) 22:895–912.
Stein, O., and Stein, Y., 1976, High density lipoproteins reduce the uptake of low density lipoproteins by human endothelial cells in culture, Biochim. Biophys. Acta 431:363–368.
Thompson, G. R., and Myant, N. B., 1976, Low density lipoprotein turnover in familial hypercholesterolaemia after plasma exchange, Atherosclerosis 23:371–377.
Tyroler, H. A., Hames, C. G., Krishan, I., Heyden, S., Cooper, G., and Cassel, J. C., 1975, Black-white differences in serum lipids and lipoproteins in Evans county, Prev. Med. 4:541–549.
Walton, K. W., Hitchens, J., Magnani, H. N., and Khan, M., 1974, A study of methods of identification and estimation of LP(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis, Atherosclerosis 20:323–346.
West, R. J., Fosbrooke, A. S., and Lloyd, J. K., 1975, Treatment of children with familial hypercholesterolemia, Postgrad. Med. J. 51(Suppl. 8):82–86.
Witters, L. A., Herbert, P. N., Shulman, R. S., Krauss, R. M., and Levy, R. I., 1976, Therapeutic failure in familial type II hyperlipoproteinemia, Metabolism 25:1017–1026.
Wood, P. D., Haskell, W., Klein, H., Lewis, S., Stern, M. P., and Farquhar, J. W., 1976, The distribution of plasma lipoproteins in middle-aged male runners, Metabolism 25:1249–1257.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Publishing Corporation
About this chapter
Cite this chapter
Goodman, D.S. (1978). Disorders of Lipid and Lipoprotein Metabolism. In: Freinkel, N. (eds) The Year in Metabolism 1977. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2499-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2499-7_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2501-7
Online ISBN: 978-1-4684-2499-7
eBook Packages: Springer Book Archive